Antibacterial peptide for maintaining oral flora balance and preparation method and application thereof

By designing antibacterial peptides used to maintain oral bacterial flora balance, the problems of bacterial resistance and oral flora imbalance caused by existing antibacterial agents are solved, effectively inhibiting oral pathogenic bacteria and protecting gum health are achieved, and are suitable for Prevent and treat a variety of oral diseases.

CN118955639AActive Publication Date: 2024-11-15METANOVAS BIOTECH (SHANGHAI) CO LTD

Patent Information

Application Number
CN202411282292.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-12
Publication Date
2024-11-15
Estimated Expiration
2044-09-12

AI Technical Summary

Technical Problem

Existing antibacterial agents can easily lead to bacterial resistance and oral flora imbalance after long-term use, and cannot effectively prevent and treat gum diseases.

Method used

An antibacterial peptide for maintaining oral bacterial flora balance was designed, prepared by solid phase synthesis method, which has antibacterial and bactericidal activity against oral pathogenic bacteria but does not affect the growth of beneficial bacteria. It is suitable for the preparation of oral antibacterial agents and Related supplies.

Benefits of technology

It has achieved effective inhibition and bactericidal bacteria on oral pathogenic bacteria, maintained the balance of oral bacterial flora, and protected the health of gums. It is suitable for the prevention and treatment of diseases such as caries, periodontitis and oral mucosal diseases, and is difficult to synthesize and has clear effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118955639A_ABST
    Figure CN118955639A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of antibacterial peptides, in particular to an antibacterial peptide for maintaining oral flora balance and a preparation method and application thereof. The antibacterial peptide for maintaining oral flora balance comprises any one of the following polypeptides (a)-(e): (a) a polypeptide of which the amino acid sequence comprises an amino acid sequence as shown in SEQ ID NO.1; (b) an amino acid residue with an amino acid sequence as shown in SEQ ID NO.1; (c) a polypeptide formed by substitution and / or deletion and / or addition of one or more amino acid residues on the amino acid sequence defined by (a) or (b); (d) a polypeptide having more than 99%, more than 95%, more than 90%, more than 85% or more than 80% homology with the amino acid sequence defined by (a) or (b); and (e) a polypeptide obtained by modifying an N terminal and / or a C terminal of any polypeptide defined in (a)-(d). The antibacterial peptide for maintaining oral flora balance has bacteriostatic and bactericidal activity on oral pathogenic bacteria, does not affect normal growth of beneficial bacteria, has the function of maintaining oral flora balance, protects gingival health and refreshes breath. The antibacterial peptide is suitable for preparing an oral cavity bacteriostatic agent and related oral cavity products, can regulate the balance of oral cavity micro-ecology, and is further used for preventing and treating oral cavity diseases, especially diseases such as caries, periodontitis, oral mucosal diseases or oral cancer. The antibacterial peptide is short in length, small in chemical synthesis difficulty, capable of being directly synthesized into a high-purity product, clear in effect and wide in application.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of antimicrobial peptides, and in particular relates to an antimicrobial peptide for maintaining the balance of oral flora, and a preparation method and application thereof. Background Art

[0002] In interpersonal communication, the whitening of gums and the odor of the mouth affect the conversation process and the impression of the other party. Gum diseases (such as caries, periodontal disease) and bad breath can also cause social difficulties, sleep disorders and psychological disorders, affecting people's normal life. Oral pathogens and dental plaque play a direct role in the occurrence and development of gum disease. Auxiliary treatment drugs for gum disease are mainly traditional antibiotics, and long-term use can easily cause bacterial resistance and oral flora imbalance. Therefore, there is an urgent need to develop new drugs to avoid the risk of bacterial resistance.

[0003] As a new type of antimicrobial agent, antimicrobial peptides have a wide range of sources and a broad spectrum of antimicrobial activity. Compared with traditional antibiotics, most antimicrobial peptides kill bacteria mainly by destroying bacterial cell membranes, and are not easy to cause bacteria to develop drug resistance. They are considered to be good alternatives to antibiotics. In 1980, Boman et al. successfully isolated and purified cecropin from Cecropinus pupa for the first time, which was the first antimicrobial peptide discovered. Subsequently, antimicrobial peptides were successively discovered in bacteria, fungi, amphibians, higher plants, mammals and humans. At present, more than 40 antimicrobial peptides have been isolated from human oral epithelial cells, saliva and periodontal tissues. Some antimicrobial peptides have shown antimicrobial activity against periodontal pathogens. For example, LL-37 has a killing effect on Actinobacillus actinomycetemcomitans and Prevotella intermedia, β-defensins have a killing effect on Actinobacillus actinomycetemcomitans, Fusobacterium nucleatum, Porphyromonas gingivalis and Prevotella intermedia, and lactoferrin has a killing effect on Porphyromonas gingivalis and Prevotella intermedia.

[0004] Natural antimicrobial peptides have high production costs, low antimicrobial activity, and poor stability, which cannot meet the needs of practical applications. With the continuous in-depth study of the properties, structure, and mechanism of action of existing natural antimicrobial peptides, more and more research is focused on the development of synthetic antimicrobial peptides. Researchers have successfully used various modern biotechnologies to improve the molecules of antimicrobial peptides or synthesize new antimicrobial peptides. Therefore, it is of great significance to develop antimicrobial peptides with simple structures and strong antimicrobial activity. Summary of the invention

[0005] In order to solve the problems in the prior art, the first aspect of the present invention provides an antimicrobial peptide for maintaining the balance of oral flora, wherein the antimicrobial peptide is any one of the following polypeptides (a)-(e):

[0006] (a) a polypeptide whose amino acid sequence includes the amino acid sequence shown in SEQ ID NO.1;

[0007] (b) the amino acid sequence consists of the amino acid residues shown in SEQ ID NO.1;

[0008] (c) a polypeptide formed by substituting and / or deleting and / or adding one or more amino acid residues of the amino acid sequence defined in (a) or (b);

[0009] (d) a polypeptide having 99% or more, 95% or more, 90% or more, 85% or more, or 80% or more homology with the amino acid sequence defined in (a) or (b);

[0010] (e) A polypeptide obtained by modifying the N-terminus and / or C-terminus of any of the polypeptides defined in (a) to (d).

[0011] Further preferably, the antimicrobial peptide is P14, and the amino acid sequence is shown in SEQ ID NO.1.

[0012] Preferably, the antimicrobial peptide is P14S, and the amino acid sequence is shown in SEQ ID NO.2.

[0013] The second aspect of the present invention provides a method for preparing an antimicrobial peptide for maintaining the balance of oral flora, wherein the preparation method is a solid phase synthesis method.

[0014] The third aspect of the present invention provides an application of an antimicrobial peptide for maintaining the balance of oral flora, which is applied to the preparation of oral health and beauty or pharmaceutically acceptable salts.

[0015] Preferably, the oral health and cosmetic or pharmaceutically acceptable salt is a salt formed by an antimicrobial peptide and an organic base.

[0016] Preferably, the oral health and cosmetic or pharmaceutically acceptable salt is a salt formed by the antimicrobial peptide and an inorganic acid or an organic acid.

[0017] Preferably, the antimicrobial peptide for maintaining the balance of oral flora and the oral health and cosmetic or pharmaceutically acceptable salt are used in an antibacterial agent for oral pathogenic bacteria.

[0018] Preferably, the oral pathogenic bacteria include one or more of Streptococcus mutans, Porphyromonas gingivalis, Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Listeria monocytogenes, and Stenotrophomonas maltophilia.

[0019] Preferably, the antimicrobial peptide for maintaining the balance of oral flora and the oral health and cosmetic or pharmaceutically acceptable salt are used in oral products, and the oral products are one or more of toothpaste, mouthwash, dental nerve deactivator, and anti-infective drugs.

[0020] The beneficial effects of the present invention are:

[0021] The present invention designs and synthesizes an antimicrobial peptide for maintaining the balance of oral flora. While having antibacterial and bactericidal activity against oral pathogens, it does not affect the normal growth of beneficial bacteria, has the function of maintaining the balance of oral flora, protects gum health and refreshes breath. The antimicrobial peptide is suitable for preparing oral antibacterial agents and related oral products, regulating the balance of oral microecology, and then used for preventing and treating oral diseases, especially preventing and treating dental caries, periodontitis, oral mucosal diseases or oral cancer. The antimicrobial peptide of the present invention is short in length, has low difficulty in chemical synthesis, can be directly synthesized into a high-purity product, and has clear effects and wide applications. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1A and Figure 1B The antibacterial results of the antimicrobial peptide described in Example 1 after incubation in Streptococcus mutans ATCC35668 for 24 hours and 40 hours are shown respectively;

[0023] Figure 2A and Figure 2B These are the antibacterial results of the antimicrobial peptide in Example 1 detected in Lactobacillus salivarius ATCC11741 after incubation for 24 hours and 48 hours. DETAILED DESCRIPTION

[0024] To make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention will be described in detail below. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all of the embodiments. Based on the embodiments of the present invention, all other implementation methods obtained by ordinary technicians in this field without creative work belong to the scope of protection of the present invention.

[0025] The first aspect of the present invention provides an antimicrobial peptide for maintaining the balance of oral flora, wherein the antimicrobial peptide is any one of the following polypeptides (a) to (e):

[0026] (a) a polypeptide whose amino acid sequence includes the amino acid sequence shown in SEQ ID NO.1;

[0027] (b) the amino acid sequence consists of the amino acid residues shown in SEQ ID NO.1;

[0028] (c) a polypeptide formed by substituting and / or deleting and / or adding one or more amino acid residues of the amino acid sequence defined in (a) or (b);

[0029] (d) a polypeptide having 99% or more, 95% or more, 90% or more, 85% or more, or 80% or more homology with the amino acid sequence defined in (a) or (b);

[0030] (e) A polypeptide obtained by modifying the N-terminus and / or C-terminus of any of the polypeptides defined in (a) to (d).

[0031] Further preferably, the antimicrobial peptide is P14, and the amino acid sequence is shown in SEQ ID NO.1.

[0032] Preferably, the antimicrobial peptide is P14S, and the amino acid sequence is shown in SEQ ID NO.2.

[0033] The second aspect of the present invention provides a method for preparing an antimicrobial peptide for maintaining the balance of oral flora, wherein the preparation method is a solid phase synthesis method.

[0034] The third aspect of the present invention provides an application of an antimicrobial peptide for maintaining the balance of oral flora, which is applied to the preparation of oral health and beauty or pharmaceutically acceptable salts.

[0035] Preferably, the oral health and cosmetic or pharmaceutically acceptable salt is a salt formed by an antimicrobial peptide and an organic base.

[0036] Preferably, the oral health and cosmetic or pharmaceutically acceptable salt is a salt formed by the antimicrobial peptide and an inorganic acid or an organic acid.

[0037] Preferably, the antimicrobial peptide for maintaining the balance of oral flora and the oral health and cosmetic or pharmaceutically acceptable salt are used in an antibacterial agent for oral pathogenic bacteria.

[0038] Preferably, the oral pathogenic bacteria include one or more of Streptococcus mutans, Porphyromonas gingivalis, Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Listeria monocytogenes, and Stenotrophomonas maltophilia.

[0039] Preferably, the antimicrobial peptide for maintaining the balance of oral flora and the oral health and cosmetic or pharmaceutically acceptable salt are used in oral products, and the oral products are one or more of toothpaste, mouthwash, dental nerve deactivator, and anti-infective drugs.

[0040] The above technical solution is described in detail below in conjunction with specific embodiments.

[0041] The experimental methods used in the following examples are conventional methods unless otherwise specified. The materials, reagents, etc. used in the following examples are all commercially available unless otherwise specified.

[0042] Example 1

[0043] This embodiment provides an antimicrobial peptide P14 for maintaining the balance of oral flora, and its amino acid sequence is RKVLRKLLVCKS, as shown in SEQ ID NO.1.

[0044] This embodiment further provides a method for preparing the antimicrobial peptide, which adopts a solid phase synthesis method, and the specific steps are as follows:

[0045] (1) The order of peptide synthesis is from C-terminus to N-terminus: 20g AM resin is placed in a reaction tube, 15mL / g DCM (dichloromethane) is added, and the mixture is shaken for 45 minutes; the solvent DCM is filtered off through a sand core, and a 3-fold molar excess of Fmoc-Linker-OH (CAS: 145069-56-3) is added, followed by a 6.5-fold molar excess of DIEA (N,N-diisopropylethylamine), and the mixture is shaken for 75 minutes. Seal with methanol; DMF is evaporated off by rotary evaporation, and 20mL / g 20% ​​(V / V) piperidine-DMF solvent is added, washed for 5 minutes, removed, and 20mL / g 20% ​​(V / V) piperidine-DMF solvent is added, and the mixture is washed for 20 minutes. The resin is rinsed twice with DMF (15mL / g), DCM (15mL / g), and DMF (15mL / g), respectively, and shaken for 40 minutes;

[0046] (2) Connect the first amino acid: remove the solvent DCM through a sand core, add 3.5 times molar excess of Fmoc-Ala-OH, add DMF (dimethylformamide) to dissolve, then add 6.5 times molar excess of DIEA (N,N-diisopropylethylamine), shake for 70 minutes, and block with methanol.

[0047] (3) Deprotection: DMF was evaporated off by rotary evaporation, 20 mL / g of 20% (V / V) piperidine-DMF solvent was added, washed for 5 minutes, removed, and 15 mL / g of 20% (V / V) piperidine-DMF solvent was added, and washed for 20 minutes.

[0048] (4) Detection: Draw piperidine solution, take 15 resin pellets, wash three times with ethanol, add detection reagent for detection. Heat at 105-110℃ for 8 minutes. A positive reaction is indicated when the color changes to dark blue.

[0049] (5) Rinse the resin: Rinse the resin twice with DMF (15 mL / g), DCM (15 mL / g), and DMF (15 mL / g) respectively.

[0050] (6) Condensation: Add three times excess of the next amino acid derivative (from C-terminus to nitrogen-terminus) dissolved in DMF, 3.5 times excess of HBTU (benzotriazole-N,N,N',N'-tetramethyluronium hexafluorophosphate) dissolved in DMF into the reaction tube, and then immediately add 16 times molar amount of DIEA and react for 40 minutes.

[0051] (7) Detection: Take 15 resin beads, wash them three times with ethanol, add detection reagent for detection, heat at 105℃-110℃ for 5 minutes, and a colorless reaction indicates a negative reaction.

[0052] (8) Rinse the resin: Rinse the resin twice with DMF (10 mL / g), DCM (10 mL / g), and DMF (10 mL / g) respectively.

[0053] (9) Repeat steps (3) to (8) to connect the amino acids shown in SEQ ID No. 1 from right to left.

[0054] (10) Drain and wash the resin as follows: DMF (15 mL / g) twice, methanol (15 mL / g) twice, DMF (15 mL / g) twice, and DCM (15 mL / g) twice. Drain for 10 min.

[0055] (11) Cutting the polypeptide from the resin: The cutting solution used at 25°C contains: 95% (V / V) TFA (trifluoroacetic acid), 1% (V / V) water, 2% (V / V) EDT (mercaptoethanol), and 2% (V / V) TIS (triisopropylsilane); the cutting time is 120 minutes, and the cleavage solution is obtained.

[0056] (12) Blow-drying and washing: The lysate was blown dry with nitrogen, washed with ether six times, and then left to evaporate at room temperature.

[0057] (13) Analysis, purification and freeze drying: The crude polypeptide was purified by high performance liquid chromatography; the polypeptide solution was collected and placed in a freeze dryer for concentration, and freeze-dried to obtain a white powder, thereby obtaining an antimicrobial peptide with the structure of RKVLRKLLVCKS.

[0058] The detection reagent is ninhydrin.

[0059] Example 2

[0060] This embodiment provides an antimicrobial peptide P14S for maintaining the balance of oral flora, and its amino acid sequence is RKVLRKLLVSKS, as shown in SEQ ID NO.2.

[0061] This embodiment further provides a method for preparing the antimicrobial peptide, which adopts a solid phase synthesis method, and the specific steps are as follows:

[0062] (1) The order of peptide synthesis is from C-terminus to N-terminus: 20g AM resin is placed in a reaction tube, 15mL / g DCM (dichloromethane) is added, and the mixture is shaken for 45 minutes; the solvent DCM is filtered off through a sand core, and a 3-fold molar excess of Fmoc-Linker-OH (CAS: 145069-56-3) is added, followed by a 6.5-fold molar excess of DIEA (N,N-diisopropylethylamine), and the mixture is shaken for 75 minutes. Seal with methanol; DMF is evaporated off by rotary evaporation, and 20mL / g 20% ​​(V / V) piperidine-DMF solvent is added, washed for 5 minutes, removed, and 20mL / g 20% ​​(V / V) piperidine-DMF solvent is added, and the mixture is washed for 20 minutes. The resin is rinsed twice with DMF (15mL / g), DCM (15mL / g), and DMF (15mL / g), respectively, and shaken for 40 minutes;

[0063] (2) Connect the first amino acid: remove the solvent DCM through a sand core, add 3.5 times molar excess of Fmoc-Ala-OH, add DMF (dimethylformamide) to dissolve, then add 6.5 times molar excess of DIEA (N,N-diisopropylethylamine), shake for 70 minutes, and block with methanol.

[0064] (3) Deprotection: DMF was evaporated off by rotary evaporation, 20 mL / g of 20% (V / V) piperidine-DMF solvent was added, washed for 5 minutes, removed, and 15 mL / g of 20% (V / V) piperidine-DMF solvent was added, and washed for 20 minutes.

[0065] (4) Detection: Draw piperidine solution, take 15 resin pellets, wash three times with ethanol, add detection reagent for detection. Heat at 105-110℃ for 8 minutes. A positive reaction is indicated when the color changes to dark blue.

[0066] (5) Rinse the resin: Rinse the resin twice with DMF (15 mL / g), DCM (15 mL / g), and DMF (15 mL / g) respectively.

[0067] (6) Condensation: Add three times excess of the next amino acid derivative (from C-terminus to nitrogen-terminus) dissolved in DMF, 3.5 times excess of HBTU (benzotriazole-N,N,N',N'-tetramethyluronium hexafluorophosphate) dissolved in DMF into the reaction tube, and then immediately add 16 times molar amount of DIEA and react for 40 minutes.

[0068] (7) Detection: Take 15 resin beads, wash them three times with ethanol, add detection reagent for detection, heat at 105℃-110℃ for 5 minutes, and a colorless reaction indicates a negative reaction.

[0069] (8) Rinse the resin: Rinse the resin twice with DMF (10 mL / g), DCM (10 mL / g), and DMF (10 mL / g) respectively.

[0070] (9) Repeat steps (3) to (8) to connect the amino acids shown in SEQ ID No. 2 from right to left.

[0071] (10) Drain and wash the resin as follows: DMF (15 mL / g) twice, methanol (15 mL / g) twice, DMF (15 mL / g) twice, and DCM (15 mL / g) twice. Drain for 10 min.

[0072] (11) Cutting the polypeptide from the resin: The cutting solution used at 25°C contains: 95% (V / V) TFA (trifluoroacetic acid), 1% (V / V) water, 2% (V / V) EDT (mercaptoethanol), and 2% (V / V) TIS (triisopropylsilane); the cutting time is 120 minutes, and the cleavage solution is obtained.

[0073] (12) Blow-drying and washing: The lysate was blown dry with nitrogen, washed with ether six times, and then left to evaporate at room temperature.

[0074] (13) Analysis, purification and freeze drying: The crude polypeptide was purified by high performance liquid chromatography; the polypeptide solution was collected and placed in a freeze dryer for concentration, and freeze-dried to obtain a white powder, thereby obtaining an antimicrobial peptide with the structure of RKVLRKLLVSKS.

[0075] The detection reagent is ninhydrin.

[0076] Experimental example

[0077] 1. Antibacterial experiment:

[0078] The antibacterial test of the antimicrobial peptide P14 described in Example 1 was carried out in a liquid culture medium. The inoculation concentration of Streptococcus mutans was 10 3 CFU, Lactobacillus salivarius inoculation concentration 5×10 5 CFU.

[0079] The bacteria are Streptococcus mutans ATCC35668 and Lactobacillus salivarius ATCC11741, and CAP is chloramphenicol as a control group, which are all commercially available.

[0080] 2. Experimental results

[0081] The results of the antibacterial test on Streptococcus mutans are as follows Figure 1A and Figure 1BAs shown, after adding 10 μg / mL of antimicrobial peptide and incubating for 24 hours, the inhibition rate of Streptococcus mutans reached 100%; after continuous incubation for 40 hours, absorbance measurement showed that the 100% antibacterial effect still existed, indicating that the antimicrobial peptide of the present invention has an inhibitory effect on Streptococcus mutans.

[0082] The results of the antibacterial test on Lactobacillus salivarius are as follows Figure 2A and Figure 2B As shown, after adding 40 μg / mL antimicrobial peptides and incubating for 24 hours, there was no inhibitory effect on Lactobacillus salivarius; after continuous incubation for 40 hours, the absorbance measurement showed that Lactobacillus salivarius was still not inhibited, indicating that the antimicrobial peptides had no inhibitory effect on Lactobacillus salivarius.

[0083] The present invention designs and synthesizes an antimicrobial peptide for maintaining the balance of oral flora, which has antibacterial and bactericidal activity against oral pathogens (such as Streptococcus mutans) while not affecting the normal growth of beneficial bacteria (such as Lactobacillus salivarius), and has the function of maintaining the balance of oral flora, protecting gum health and refreshing breath. The antimicrobial peptide is suitable for preparing oral antibacterial agents and related oral products, regulating the balance of oral microecology, and then used for preventing and treating oral diseases, especially preventing and treating dental caries, periodontitis, oral mucosal diseases or oral cancer and other diseases. The antimicrobial peptide of the present invention is short in length, has low difficulty in chemical synthesis, can be directly synthesized into a high-purity product, and has clear effects and wide applications.

[0084] The above is only a specific embodiment of the present invention, but the protection scope of the present invention is not limited thereto. Any person skilled in the art can easily think of changes or substitutions within the technical scope disclosed by the present invention, which should be included in the protection scope of the present invention. Therefore, the protection scope of the present invention should be based on the protection scope of the claims.

Claims

1. An antimicrobial peptide for maintaining the balance of oral flora, characterized in that: The antimicrobial peptide is any one of the following polypeptides (a)-(e): (a) a polypeptide whose amino acid sequence includes the amino acid sequence shown in SEQ ID NO.1; (b) the amino acid sequence consists of the amino acid residues shown in SEQ ID NO.1; (c) a polypeptide formed by substituting and / or deleting and / or adding one or more amino acid residues of the amino acid sequence defined in (a) or (b); (d) a polypeptide having 99% or more, 95% or more, 90% or more, 85% or more, or 80% or more homology with the amino acid sequence defined in (a) or (b); (e) A polypeptide obtained by modifying the N-terminus and / or C-terminus of any of the polypeptides defined in (a) to (d).

2. The antimicrobial peptide for maintaining the balance of oral flora according to claim 1, characterized in that: The antimicrobial peptide is P14, and the amino acid sequence is shown in SEQ ID NO.

1.

3. The antimicrobial peptide for maintaining the balance of oral flora according to claim 1, characterized in that: The antimicrobial peptide is P14S, and the amino acid sequence is shown in SEQ ID NO.

2.

4. A method for preparing an antimicrobial peptide for maintaining the balance of oral flora according to any one of claims 1 to 3, characterized in that: The preparation method is a solid phase synthesis method.

5. Use of the antimicrobial peptide according to any one of claims 1 to 3 in the preparation of oral health and beauty or pharmaceutically acceptable salts.

6. The use according to claim 5, characterized in that: The oral health and cosmetic or pharmaceutically acceptable salt is a salt formed by the antimicrobial peptide and an organic base.

7. The use according to claim 5, characterized in that: The oral health and cosmetic or pharmaceutically acceptable salt is a salt formed by the antimicrobial peptide and an inorganic acid or an organic acid.

8. Use of the antimicrobial peptide for maintaining the balance of oral flora according to any one of claims 1 to 3, and the oral health and cosmetic or pharmaceutically acceptable salt according to any one of claims 6 to 7 in an oral pathogenic bacteria inhibitor.

9. The use according to claim 8, characterized in that: The oral pathogenic bacteria include one or more of Streptococcus mutans, Porphyromonas gingivalis, Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Listeria, and Stenotrophomonas maltophilia.

10. Use of the antimicrobial peptide for maintaining the balance of oral flora according to any one of claims 1 to 3 and the oral health and cosmetic or pharmaceutically acceptable salt according to any one of claims 6 to 7 in oral products, characterized in that: The oral product is one or more of toothpaste, mouthwash, dental nerve deactivator, and anti-infection medicine.

Citation Information

Patent Citations

  • Antibacterial peptide for killing oral cariogenic bacteria and inhibiting formation of dental plaque and application thereof

    CN108704119A

  • Polypeptide resistant to oral pathogens and application

    CN110317247A

  • Gum protection antibacterial peptide or stereoisomerism thereof, and preparation method and application thereof

    CN116947977A

  • Application of antibacterial peptide compound DM80bu20 in preparation of antibacterial toothpaste

    WO2023029137A1

Cited By

  • Antibacterial peptide, preparation method and application of antibacterial peptide in prevention and treatment of oral cavity problems

    CN121974983A

  • An antimicrobial peptide, its preparation method, and its application in the prevention and treatment of oral problems.

    CN121974983B

  • Antibacterial peptide and application thereof in prevention and treatment of periodontal problems

    CN122036909A